(Q33396236)

26 July 2017

1 reference

title

Use of monoclonal antibodies in renal transplantation (English)

1 reference

26 July 2017

1 reference

1 reference

Luuk B Hilbrands

2

0 references

author name string

Martijn W F van den Hoogen

series ordinal

1

1 reference

26 July 2017

publication date

1 July 2011

1 reference

26 July 2017

1 reference

26 July 2017

volume

3

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

871-880

1 reference

Rejection of the kidney allograft

26 July 2017

cites work

1 reference

Mechanisms involved in antibody- and complement-mediated allograft rejection

21 January 2018

1 reference

Toward more selective therapies to block undesired immune responses

21 January 2018

1 reference

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

21 January 2018

1 reference

Treatment of first acute rejection episode: systematic review of level I evidence

21 January 2018

1 reference

T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients.

21 January 2018

1 reference

Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients

21 January 2018

1 reference

Reversal of acute cellular rejection after renal transplantation with Campath-1H.

21 January 2018

1 reference

Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.

21 January 2018

1 reference

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.

21 January 2018

1 reference

Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial

21 January 2018

1 reference

Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results

21 January 2018

1 reference

Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

21 January 2018

1 reference

Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation

21 January 2018

1 reference

A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.

21 January 2018

1 reference

A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up

21 January 2018

1 reference

Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation

21 January 2018

1 reference

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

21 January 2018

1 reference

Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine

21 January 2018

1 reference

Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials

21 January 2018

1 reference

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

21 January 2018

1 reference

Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation

21 January 2018

1 reference

Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data

21 January 2018

1 reference

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

21 January 2018

1 reference

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients

21 January 2018

1 reference

Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study

21 January 2018

1 reference

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation

21 January 2018

1 reference

ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.

21 January 2018

1 reference

ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up

21 January 2018

1 reference

ABO-incompatible kidney transplantation: current practice and the decade ahead

21 January 2018

1 reference

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

21 January 2018

1 reference

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

21 January 2018

1 reference

Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts.

21 January 2018

1 reference

Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.

21 January 2018

1 reference

Rituximab as treatment for refractory kidney transplant rejection

21 January 2018

1 reference

Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection

21 January 2018

1 reference

A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation.

21 January 2018

1 reference

B-cell-depleting induction therapy and acute cellular rejection

21 January 2018

1 reference

Posttransplant recurrence of primary glomerulonephritis

21 January 2018

1 reference

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines.

21 January 2018

1 reference

Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study

21 January 2018

1 reference

Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature

21 January 2018

1 reference

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

21 January 2018

1 reference

New insights into postrenal transplant hemolytic uremic syndrome.

21 January 2018

1 reference

Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.

21 January 2018

1 reference

A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

21 January 2018

1 reference

Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients

21 January 2018

1 reference

Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion

21 January 2018

1 reference

Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft

21 January 2018

1 reference

What's next in the pipeline

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.11.72

1 reference

26 July 2017

1 reference